US Stock MarketDetailed Quotes
CNTX Context Therapeutics
- 1.1400
- -0.0100-0.87%
Close Dec 26 16:00 ET
- 1.1400
- 0.00000.00%
Post 17:06 ET
85.50MMarket Cap-1.30P/E (TTM)
1.2500High1.0800Low286.69KVolume1.1200Open1.1500Pre Close331.69KTurnover0.74%Turnover RatioLossP/E (Static)75.00MShares2.750052wk High1.02P/B44.40MFloat Cap0.890052wk Low--Dividend TTM38.95MShs Float10.8700Historical High--Div YieldTTM14.78%Amplitude0.4700Historical Low1.1560Avg Price1Lot Size
Context Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.14%-1.93M | 27.54%-3.36M | 23.88%-4.36M | -55.34%-21.05M | -83.91%-7.23M | -15.59%-3.46M | -65.09%-4.63M | -49.95%-5.73M | -53.98%-13.55M | 20.80%-3.93M |
| Net income from continuing operations | -197.21%-17.46M | 55.01%-2.25M | 41.86%-3.67M | -61.53%-23.96M | -90.34%-6.77M | -52.42%-5.87M | -25.71%-5.01M | -83.47%-6.31M | -41.88%-14.84M | -15.04%-3.56M |
| Operating gains losses | ---- | ---- | ---- | -33.82%51.97K | --0 | -65.01%7.52K | 5.44%22.37K | 57.44%22.08K | -68.12%78.52K | --21.79K |
| Depreciation and amortization | -9.00%2.81K | -19.60%2.57K | -19.57%2.57K | 29.95%12.04K | -19.60%2.57K | -3.26%3.09K | 10.86%3.19K | --3.19K | --9.27K | --3.19K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -84.00%500K | --0 |
| Change In working capital | -74.67%544.25K | -1,862.27%-1.26M | -444.11%-935.4K | 739.84%1.78M | -11.60%-715.91K | 284.30%2.15M | -82.80%71.55K | 144.50%271.83K | 87.53%-277.52K | 68.80%-641.51K |
| -Change in prepaid assets | -108.42%-107.63K | 53.35%-212.14K | 170.55%647.9K | 203.09%758.83K | -294.95%-303.85K | 236.90%1.28M | -1.16%-454.72K | -51.23%239.48K | 54.32%-736.05K | 109.73%155.86K |
| -Change in payables and accrued expense | -21.79%668.16K | -291.45%-1.05M | -3,317.81%-1.58M | 83.39%1.04M | 47.23%-412.05K | -42.54%854.29K | -41.21%547.78K | 104.59%49.2K | 192.39%566.69K | -71.92%-780.82K |
| -Change in other current assets | --0 | --0 | --0 | 200.00%32.75K | --0 | -15.60%24K | 105.00%2.19K | 127.34%6.56K | ---32.75K | --6.56K |
| -Change in other current liabilities | -104.32%-16.28K | --0 | --0 | 26.96%-55.08K | --0 | 65.11%-7.97K | -5.12%-23.7K | -238.72%-23.41K | ---75.41K | ---23.12K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.14%-1.93M | 27.54%-3.36M | 23.88%-4.36M | -55.34%-21.05M | -83.91%-7.23M | -15.59%-3.46M | -65.09%-4.63M | -49.95%-5.73M | -53.98%-13.55M | 20.80%-3.93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -114.73%-536.84K | 0 | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---36.84K | --0 |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -100.00%-500K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -114.73%-536.84K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -44.63K | 0 | 0 | 0 | -100.17%-102.07K | 0 | ||||
| Net common stock issuance | ---44.63K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---102.07K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---44.63K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -100.17%-102.07K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 303.92%101.54M | -66.11%10.09M | -59.29%14.45M | -28.56%35.5M | -45.02%21.68M | -41.43%25.14M | -34.90%29.77M | -28.56%35.5M | 14,468.97%49.69M | 9,306.40%39.43M |
| Current changes in cash | -383.55%-16.74M | 2,074.64%91.45M | 23.88%-4.36M | -48.35%-21.05M | -83.91%-7.23M | 0.95%-3.46M | -64.98%-4.63M | -44.75%-5.73M | -128.75%-14.19M | -107.98%-3.93M |
| End cash Position | 291.21%84.8M | 303.92%101.54M | -66.11%10.09M | -59.29%14.45M | -59.29%14.45M | -45.02%21.68M | -41.43%25.14M | -34.90%29.77M | -28.56%35.5M | -28.56%35.5M |
| Free cash flow | -382.27%-16.69M | 27.54%-3.36M | 23.88%-4.36M | -49.42%-21.05M | -83.91%-7.23M | 0.95%-3.46M | -64.98%-4.63M | -48.59%-5.73M | -55.66%-14.09M | 20.80%-3.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
